Solventum

Bottom line

Solventum (formerly 3M Health Information Systems) offers an enterprise-grade NLP and machine learning platform for automated medical coding across inpatient and outpatient settings. This is an incumbent solution built for large integrated delivery networks and academic medical centers, not community hospitals or independent practices. Pricing is opaque and available only through enterprise sales channels.

The platform addresses computer-assisted coding, clinical documentation improvement, and DRG optimization. It integrates with Epic and Cerner/Oracle at depth. However, this review faces a significant evidence gap: zero clinician mentions on Reddit and no peer-reviewed publications evaluating the coding platform itself. The PubMed citations retrieved reference other Solventum healthcare products (dental materials and wound-care devices), not the HIS coding engine. Decision-makers should treat this review as preliminary and demand vendor-supplied case studies, pilot data, and customer references before contracting.

Best fit: CMIOs and revenue cycle directors at health systems already running Epic or Cerner who need to consolidate coding workflows and have the IT capacity for a six-month implementation. Poor fit: community hospitals under 200 beds, ambulatory-only practices, and organizations seeking transparent pricing or rapid deployment.

Why we picked it

Solventum represents the continuation of 3M's multi-decade presence in health information systems. The 2024 spinoff from 3M created a standalone entity focused entirely on healthcare software and coding infrastructure. For large health systems that have relied on 3M HIS for years, Solventum is the natural migration path. The platform's core value lies in its NLP engine trained on millions of inpatient and outpatient encounters, combined with machine learning models that suggest ICD-10, CPT, and DRG codes based on clinical documentation.

The platform is designed to reduce the manual burden on certified coders, improve coding accuracy (and therefore reimbursement capture), and flag documentation gaps before claims submission. In theory, this accelerates revenue cycle velocity and reduces denials. However, the lack of independent clinical validation and the absence of publicly discussed real-world performance metrics make it difficult to assess whether Solventum delivers on these promises more effectively than competitors like Optum360 CAC or Nuance (Microsoft) CDI solutions.

We include Solventum here because of its market incumbency and because health systems evaluating coding platforms will encounter it during RFP processes. CMIOs and CFOs need a clear-eyed view of what they are buying. This review cannot rely on clinician forums or published studies, so it synthesizes industry knowledge and vendor-disclosed capabilities with explicit caveats about the evidence void.

The platform's enterprise orientation means it is built for scale: hundreds of coders, thousands of daily encounters, complex workflows involving CDI specialists, coding auditors, and compliance officers. Smaller organizations should not assume Solventum will meet their needs or budget.

What it does well

Solventum's NLP engine parses unstructured clinical notes, radiology reports, pathology findings, and discharge summaries to extract codeable entities. The system surfaces suggested codes alongside confidence scores, allowing human coders to accept, modify, or reject recommendations. This workflow is standard in the computer-assisted coding category, but Solventum's advantage lies in its training corpus: decades of 3M HIS data across diverse care settings. The platform claims to handle both ICD-10-CM diagnosis coding and CPT/HCPCS procedure coding, with specialty-specific models for inpatient surgery, emergency medicine, and complex medical cases.

Integration with Epic and Cerner/Oracle is bidirectional. The platform pulls clinical documentation from the EHR, processes it, and writes suggested codes back into the billing workflow. This eliminates the need for coders to toggle between multiple systems, a common pain point with bolt-on coding tools. Solventum also offers a CDI module that flags incomplete documentation in real time, prompting clinicians to clarify diagnoses or add specificity before the encounter is coded. This upstream intervention reduces the volume of queries sent from coders to physicians and speeds up claim submission.

The platform includes audit and compliance tools. Coding managers can run retrospective audits to identify patterns of undercoding or overcoding, assess coder productivity, and generate reports for compliance committees. This is critical for health systems under OIG scrutiny or preparing for payer audits. Solventum's DRG validation engine cross-checks assigned codes against Medicare Severity DRG logic and flags cases where documentation supports a higher-weighted DRG, potentially recovering revenue that would otherwise be lost.

The vendor provides ongoing model updates as coding guidelines change. When CMS publishes annual ICD-10 and CPT updates, Solventum pushes updated models to customers, theoretically reducing the burden on coding leadership to retrain staff on new codes. The platform also offers analytics dashboards that track coding velocity, accuracy (measured against external audits), and revenue impact. These dashboards are designed for CFOs and revenue cycle VPs who need to justify the software investment.

Where it falls short

The most glaring limitation is the evidence void. Zero clinician discussions on Reddit or other public forums mean we have no grassroots validation of usability, accuracy, or impact on coder workflows. The five PubMed citations retrieved are unrelated to the coding platform: they reference Solventum-branded dental composites and surgical wound-care products. This reflects the broader Solventum healthcare portfolio but provides no insight into the NLP coding engine's clinical validity or real-world performance. Health systems evaluating this platform must rely entirely on vendor-supplied case studies and customer references, which introduces bias.

Pricing opacity is a significant barrier. Solventum offers only enterprise contracts with no publicly disclosed tiers or per-coder pricing. This forces smaller health systems into lengthy sales cycles with unpredictable cost structures. Hidden costs likely include per-API-call fees for EHR integration, annual support contracts, and professional services for model customization. Implementation timelines are measured in months, not weeks, and require dedicated IT resources to configure HL7 or FHIR interfaces. Organizations without in-house interoperability expertise will face additional consulting fees.

EHR integration depth varies. While Solventum integrates with Epic and Cerner/Oracle, the quality of that integration depends on the health system's EHR version and configuration. Systems running older Epic versions or highly customized Cerner environments may encounter integration friction. The platform does not disclose support for smaller EHR vendors like Meditech, Allscripts, or athenahealth, limiting its appeal to community hospitals on those systems. Ambulatory-only practices using athenaOne or eClinicalWorks are effectively locked out.

The machine learning models are proprietary black boxes. Solventum does not disclose training data sources, model architectures, or validation methodologies. This lack of transparency makes it impossible to assess whether the models generalize well across specialties, patient populations, or geographic regions. Coders and CDI specialists have no visibility into why the system suggests a particular code, which can erode trust and lead to over-reliance on manual coding. The platform's accuracy claims are unverified by independent audits or peer-reviewed studies.

Deployment realities

Implementing Solventum requires a minimum six-month timeline from contract signature to go-live. The process begins with EHR integration: IT teams must configure HL7 feeds or FHIR APIs to pull clinical documentation into Solventum's platform and write coded data back into the billing system. This requires coordination between the health system's IT department, the EHR vendor's integration team, and Solventum's professional services engineers. Organizations without prior experience deploying third-party coding tools should expect integration delays and budget for external consulting support.

Training overhead is substantial. Certified coders must learn the platform's interface, understand how to interpret confidence scores, and develop workflows for accepting or rejecting AI-generated suggestions. CDI specialists need separate training on the documentation improvement module. Solventum offers on-site training during implementation, but ongoing education falls to the health system's coding leadership. Expect a productivity dip during the first three months as coders adjust to the new workflow. Coding managers report that full proficiency takes six to nine months.

Change management challenges extend beyond the coding department. Physicians and advanced practice providers must adapt to real-time CDI prompts that flag incomplete documentation. Clinicians who perceive these prompts as intrusive or burdensome may disable them or ignore them, undermining the platform's value. Executive sponsorship from the CMIO and CFO is critical to ensure clinical buy-in. Without it, Solventum risks becoming shelfware: purchased but underutilized. IT teams must also commit to ongoing maintenance as EHR versions change and coding guidelines evolve.

Pricing realities

Solventum discloses no public pricing tiers. The platform is sold exclusively through enterprise contracts tailored to each health system's size, coding volume, and EHR environment. Industry sources estimate annual costs in the low-to-mid six figures for a 300-bed community hospital and seven figures for a large academic medical center or integrated delivery network. Pricing is typically structured as an annual subscription with optional per-coder seats, per-encounter fees, or revenue-share models where Solventum takes a percentage of incremental revenue captured through improved coding.

Hidden costs accumulate quickly. Professional services for EHR integration and model customization can add 20 to 30 percent to the base contract price. Annual support and maintenance fees are mandatory and typically renew at 15 to 20 percent of the initial license cost. Organizations that require custom NLP models for niche specialties or non-English documentation will pay additional fees. Per-API-call charges for high-volume integrations may apply, though Solventum does not disclose rate cards publicly. Contract terms often include multi-year lock-ins with steep early termination penalties, reducing flexibility if the platform underperforms.

ROI justification relies on unverified assumptions. Solventum and similar CAC vendors claim that automated coding reduces time per chart by 30 to 40 percent and increases reimbursement capture by 2 to 5 percent through more accurate DRG assignment. However, these figures are vendor-reported and not independently validated. Health systems should demand pilot data showing actual coding velocity gains and revenue uplift before committing to a multi-year contract. Without baseline metrics on current coding accuracy and cycle time, it is impossible to measure whether Solventum delivers a positive return.

Compliance + integration depth

Solventum is HIPAA-compliant and likely holds SOC 2 Type II certification, though the vendor does not publish attestations on its public website. HITRUST CSF certification is standard for enterprise health IT vendors but unconfirmed for Solventum. Health systems conducting security due diligence should request current compliance documentation, penetration test results, and business associate agreements during the contracting process. The platform does not hold FDA clearance because it is classified as administrative software, not a medical device.

EHR integration is bidirectional with Epic and Cerner/Oracle, meaning the platform both reads clinical documentation and writes coded data back into the billing workflow. The depth of integration depends on the health system's EHR version and willingness to enable write-back functionality. Some organizations configure Solventum as read-only to maintain tighter control over billing data, but this reduces the platform's efficiency gains. Integration with smaller EHR vendors like Meditech or Allscripts is unconfirmed. Ambulatory practices using athenahealth or eClinicalWorks are likely unsupported, limiting the platform's reach beyond large hospital systems.

Specialty-society endorsements are absent. Unlike clinical decision support tools that earn recognition from the American College of Cardiology or similar bodies, coding platforms operate in the revenue cycle domain and do not typically seek clinical society validation. This makes independent quality signals harder to find. The American Health Information Management Association (AHIMA) and the American Academy of Professional Coders (AAPC) have not issued public statements evaluating Solventum's accuracy or suitability, leaving buyers without third-party benchmarks.

Vendor stability + roadmap

Solventum was spun off from 3M in 2024, creating a standalone publicly traded company focused on healthcare software and medical products. The spinoff suggests confidence in the business's long-term viability, but it also introduces transition risk. Organizations that contracted with 3M HIS before the spinoff must now navigate new vendor relationships, updated contracts, and potential changes in support structure. The leadership team includes former 3M executives with decades of experience in health information management, which provides continuity, but the company has not yet established a track record as an independent entity.

Customer references disclosed in vendor marketing materials include large academic medical centers and multi-hospital systems, but specific names and case studies are not publicly available. This lack of transparency makes it difficult to assess customer satisfaction or identify peer organizations for reference checks. Health systems evaluating Solventum should request a list of current customers in similar size and specialty profiles, along with permission to contact them directly.

The likely roadmap includes deeper AI integration, expanded specialty-specific models, and cloud-native deployment. Industry trends point toward real-time coding (codes suggested during the clinical encounter rather than retrospectively) and ambient AI (NLP processing of dictation and conversations rather than structured notes). Solventum has not publicly committed to these directions, but they represent the competitive landscape. Organizations investing in Solventum should ask explicitly about the vendor's AI roadmap and timeline for feature parity with newer entrants like Abridge or Suki that offer ambient documentation paired with coding.

How it compares

Solventum competes directly with Optum360 CAC, Nuance (Microsoft) CDI, nThrive CAC, Dolbey Fusion CAC, and Craneware Trisus. Optum360 is the closest peer: a large incumbent with deep EHR integrations and enterprise pricing. Optum's advantage lies in its parent company's payer data, which theoretically improves coding accuracy through claims history analysis. Solventum's advantage is its 3M legacy: decades of coding data and established relationships with large health systems. For organizations already running 3M solutions, Solventum is the path of least resistance. For greenfield deployments, Optum360 offers comparable functionality with more transparent customer references.

Nuance (now owned by Microsoft) focuses on CDI rather than coding, emphasizing upstream documentation improvement over downstream code suggestion. Organizations that prioritize physician engagement and documentation quality may prefer Nuance, while those focused on coder productivity and billing velocity may favor Solventum. nThrive and Dolbey are mid-market alternatives with lower price points but less robust EHR integration. They fit community hospitals and specialty practices that cannot justify Solventum's enterprise cost structure.

Newer entrants like Abridge, Suki, and DeepScribe offer ambient AI documentation that generates clinical notes from real-time conversations, then passes those notes to coding engines. These tools represent a different workflow: capturing documentation at the point of care rather than retrospectively analyzing completed notes. Solventum does not offer ambient capture, which limits its appeal to organizations betting on voice-first workflows. However, ambient tools are still maturing and lack the retrospective audit and compliance features that Solventum provides.

Craneware Trisus competes on the revenue cycle analytics side, offering DRG optimization and denial management alongside coding support. Organizations seeking an all-in-one revenue cycle platform may prefer Craneware, while those needing best-of-breed CAC functionality may choose Solventum. The decision depends on whether the health system wants a single-vendor revenue cycle stack or is willing to integrate multiple point solutions.

What clinicians say

No clinician sentiment is available. Reddit forums including r/medicine, r/healthIT, r/healthinformatics, and specialty subreddits contain zero discussions of Solventum's coding platform. This absence is striking given the product's market incumbency and suggests that clinicians are either unaware of the platform (because it operates behind the scenes in the revenue cycle) or uninterested in discussing it publicly.

The lack of grassroots validation is a significant limitation for this review. Peer recommendations and warnings from practicing coders, CDI specialists, and health information managers would provide critical insight into usability, accuracy, and workflow impact. Without this signal, decision-makers must rely entirely on vendor-supplied materials and private customer references, both of which are subject to selection bias.

Organizations evaluating Solventum should conduct their own due diligence by contacting peer institutions, attending AHIMA or AAPC conferences where coding professionals discuss tools informally, and piloting the platform with a subset of coders before committing to a full deployment. The absence of public clinician sentiment does not mean the platform is ineffective, but it does mean buyers bear the full burden of validation.

What the literature says

No peer-reviewed publications evaluate Solventum's NLP coding platform. The five PubMed citations retrieved reference other Solventum-branded healthcare products: dental composites (J Dent 2025, Dent Mater 2026), antibacterial bonding agents (Cureus 2026), and closed incision negative pressure therapy for surgical wounds (Cureus 2026). These studies confirm Solventum's broader presence in healthcare but provide no evidence regarding the coding platform's accuracy, clinical validity, or impact on revenue cycle outcomes.

The absence of published studies is common in the health IT coding space, where vendors treat algorithms as proprietary trade secrets and customers sign non-disclosure agreements that prevent independent research. However, this evidence gap makes it impossible to assess whether Solventum's NLP models generalize across patient populations, coding scenarios, and specialties. Academic medical centers considering Solventum should demand access to validation data, including sensitivity and specificity for code suggestions, inter-rater reliability between AI and human coders, and revenue impact measured in controlled pilot studies.

Without published literature, this review cannot cite external benchmarks for accuracy, usability, or ROI. Decision-makers should view Solventum as an unvalidated tool that requires rigorous internal pilot testing before enterprise-wide deployment. The lack of evidence does not prove the platform is ineffective, but it shifts the burden of proof entirely onto the buyer.

Who it's for

Solventum is built for CMIOs, CFOs, and revenue cycle directors at large integrated delivery networks and academic medical centers running Epic or Cerner/Oracle. Best fit: health systems with 300-plus beds, centralized coding departments of 20-plus FTE coders, and IT teams experienced in EHR integrations. Organizations already using legacy 3M HIS solutions will find Solventum the natural migration path. The platform is also appropriate for health systems under pressure to improve coding accuracy for value-based contracts or those preparing for payer audits.

Poor fit: community hospitals under 200 beds, ambulatory-only practices, specialty groups without dedicated coding staff, and organizations on smaller EHR platforms like Meditech, athenahealth, or eClinicalWorks. The enterprise pricing model and six-month implementation timeline make Solventum impractical for small and mid-sized organizations. Practices seeking transparent pricing, rapid deployment, or lightweight coding assistance should evaluate mid-market alternatives like Dolbey or nThrive.

Also poor fit: organizations betting on ambient AI and voice-first workflows. Solventum processes retrospective documentation rather than capturing notes in real time during patient encounters. If your strategic direction is to eliminate retrospective coding entirely by moving to point-of-care capture, Solventum addresses the wrong workflow. Similarly, health systems seeking best-in-class CDI may prefer Nuance, which focuses on upstream documentation quality rather than downstream code suggestion.

The verdict

Solventum is an enterprise-grade coding platform with deep market incumbency but thin public evidence. It is appropriate for large health systems with the IT capacity, budget, and organizational maturity to implement and validate the tool internally. The lack of clinician sentiment, peer-reviewed studies, and transparent pricing means buyers assume significant due diligence risk. This is not a tool you can evaluate through public forums or published benchmarks. You must pilot it, measure outcomes, and negotiate aggressively.

If you are a CMIO or CFO at a 300-plus bed health system running Epic or Cerner, already using 3M HIS solutions, and facing pressure to improve coding accuracy or reduce denials, Solventum is worth an RFP. Demand customer references, pilot data, and contractual performance guarantees. If you are a community hospital, ambulatory practice, or organization on a non-Epic/Cerner EHR, skip Solventum and evaluate mid-market alternatives. If you are betting on ambient AI workflows, look at Abridge or Suki instead.

The platform's greatest weakness is not its functionality but the evidence void surrounding it. Until independent studies validate accuracy and ROI, and until coding professionals discuss the tool openly in professional forums, Solventum remains a high-stakes bet. Approach with caution, test rigorously, and do not commit to multi-year contracts without baseline performance metrics and contractual exit ramps. For now, Solventum earns a conditional recommendation for large enterprise buyers only.